Robert Hoffman
2019
In 2019, Robert Hoffman earned a total compensation of $2M as Chief Financial Officer and Senior Vice President, Finance at Heron Therapeutics, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $124,388 |
|---|---|
| Option Awards | $1,512,730 |
| Salary | $388,714 |
| Other | $8,400 |
| Total | $2,034,232 |
Hoffman received $1.5M in option awards, accounting for 74% of the total pay in 2019.
Hoffman also received $124.4K in non-equity incentive plan, $388.7K in salary and $8.4K in other compensation.
Rankings
In 2019, Robert Hoffman's compensation ranked 5,833rd out of 13,971 executives tracked by ExecPay. In other words, Hoffman earned more than 58.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,833 out of 13,971 | 58th |
Division Manufacturing | 2,186 out of 5,695 | 62nd |
Major group Chemicals And Allied Products | 789 out of 2,194 | 64th |
Industry group Drugs | 664 out of 1,880 | 65th |
Industry Pharmaceutical Preparations | 488 out of 1,392 | 65th |
Pay ratio
| Robert Hoffman's Pay | $2,034,232 |
|---|---|
| Median Employee's Pay | $408,623 |
| Pay Ratio | 5to 1 |
In 2019, the annual total compensation of Robert Hoffman was $2,034,232.
The annual total compensation of the median employee at Heron Therapeutics was $408,623.
The ratio of Robert Hoffman's pay to the pay of median employee was therefore 5 to one.
Source: SEC filing on April 23, 2020.
Hoffman's colleagues
We found four more compensation records of executives who worked with Robert Hoffman at Heron Therapeutics in 2019.